Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Second generation S1P pathway modulators: Research strategies and clinical developments.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Onset of clinical and MRI efficacy occurs early after fingolimod treatment initiation in relapsing multiple sclerosis.
Impaired adult myelination in the prefrontal cortex of socially isolated mice.
Interview: Experiences targeting B cells for the treatment of multiple sclerosis.
Polypharmacy in multiple sclerosis: Relationship with fatigue, perceived cognition, and objective cognitive performance.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.
To be 17 again--anti-interleukin-17 treatment for psoriasis.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
A Patient Care Program for Adjusting the Autoinjector Needle Depth According to Subcutaneous Tissue Thickness in Patients With Multiple Sclerosis Receiving Subcutaneous Injections of Glatiramer Acetate.
Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
Patients' perspectives on quality of mental health care for people with MS.
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Neuroimmunological diseases and pregnancy.
Factors for lower walking speed in persons with multiple sclerosis.
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
Platelets and autoimmunity.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Pages